Results for
skinny label
AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringement
Reviewed by
David Brophy
on
Thursday, December 08, 2016
Rating:
5
Young EPLAW Congress: Brexit, SPCs, Skinny Labels and SEPs washed down with ample amounts of Belgian beer
Reviewed by
Annsley Merelle Ward
on
Tuesday, April 19, 2016
Rating:
5
Fordham 2016: Will purposive construction of Swiss-type claims save second-medical use patents?
Reviewed by
Annsley Merelle Ward
on
Tuesday, April 05, 2016
Rating:
5
Yet another pregabalin decision - application to amend struck out as abuse of process
Reviewed by
Darren Smyth
on
Wednesday, November 25, 2015
Rating:
5
Vive la différence? No need for Pregabalin(e) injunction, say the French
Reviewed by
Jeremy
on
Wednesday, November 11, 2015
Rating:
5
When litigants must be responsible -- and what happens when they're not: Lyrica pregabalin injunction is continued
Reviewed by
Jeremy
on
Monday, November 09, 2015
Rating:
5
The Lyrica patent dispute – part the second - infringement
Reviewed by
Darren Smyth
on
Friday, November 06, 2015
Rating:
5